Rubicon Research P/E Ratio

Current P/E Ratio
101.63
High Valuation
Very High - High growth expectations or significantly overvalued

Rubicon Research (RUBICON) P/E ratio is 101.63 (High), EPS (TTM) ₹15.52, current price ₹1520.20 on NSE vs historical average P/E of 45.71 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Rubicon Research share price today.

Current Valuation Metrics

P/E Ratio 101.63
Current Price ₹1520.20
EPS (TTM) ₹15.52
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 45.71
Historical Range 45.71 - 45.71
Percentile 100.0%

Sector Context

Sector Average 55.41
Sector Median 31.4
Sector Rank #11 of 194
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹13.35
Mar 2026 ₹4.68
Sept 2025 ₹3.49

RUBICON P/E Ratio — Valuation Signal & Historical Context

Rubicon Research P/E 101.63 vs historical average 45.71, range 45.71–45.71 — signal: Overvalued. See Rubicon Research P/B ratio trends to compare market price against book value per share.

  • Stock appears overvalued with PE of 101.63, suggesting caution for new investments
  • Current PE is 122.3% above historical average
  • Trading at premium to sector average PE of 55.41

Rubicon Research P/E Ratio Historical Trend

RUBICON annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 101.63 vs historical average 45.71. Read Rubicon Research dividend policy for the complete payout history and dividend yield track record.

RUBICON Historical P/E Ratio — EPS, Year-End Price & Valuation

Rubicon Research annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 45.71 13.13 ₹600.15 NSE High

RUBICON vs Healthcare Peers — P/E Ratio Comparison

Rubicon Research P/E 101.63 vs Healthcare average 55.41, median 31.4 — range 2.86–916.67.

Sector Average
55.41
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.61 ₹64 Low
Sunrest Lifescience SUNREST 3.76 ₹30 Low
Sun Pharma Advanced Rese… SPARC 4.76 ₹7,399 Low
Shelter Pharma SHELTER 5.23 ₹47 Low
Dipna Pharmachem DPL 5.39 ₹14 Low
JFL Life Sciences JFLLIFE 5.41 ₹68 Low
Amwill Health Care AMWILL 7.26 ₹83 Low
Zenith Drugs ZENITHDRUG 7.69 ₹84 Low
Galaxy Medicare GML 7.8 ₹27 Low